Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGNX
#3585
MacroGenics, Inc.
3.4
9
USD
+0.58%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.58%
Monthly Change
+15.18%
6 month change
+115.43%
Year Change
+166.41%
Previous Close
3.4
7
Open
3.4
9
Bid
Ask
Low
3.4
9
High
3.4
9
Volume
80
Markets
US Stock Market
Healthcare
MGNX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
56.26 M
61.32 M
61.84 M
62.43 M
63.09 M
63.56 M
—
Valuation ratios
Enterprise value
1.1 B
860.79 M
284.41 M
534.6 M
22.2 M
45.11 M
-48.4 M
Price to earnings ratio
—
-4.76
-3.26
-67.87
-3.04
-1.36
-6.38
Price to sales ratio
—
12.42
2.57
10.73
1.36
0.68
2.49
Price to cash flow ratio
—
-6.69
-4.49
-8.06
-2.98
-1.25
-4.11
Price to book ratio
—
4.02
2.75
4.13
1.75
1.83
2.6
Enterprise value to EBITDA ratio
-9.28
-4.49
-2.6
-3.37
-0.22
-0.69
0.55
Profitability ratios
Return on assets %
-0.34
-0.6
-0.43
-0.03
-0.26
-0.29
-0.32
Return on equity %
-0.44
-0.84
-0.84
-0.06
-0.58
-1.34
-1.3
Return on invested capital %
-338.26
-510.33
-323.56
-442.07
-386.54
-242.7
-426.39
Gross margin %
100
96.58
97.79
98.95
99.44
100
400
Operating margin %
-124.96
-261.85
-79.91
-286.38
-73.74
-48.72
-492.13
EBITDA margin %
-113.56
-247.31
-72.1
-269.96
-68.71
-43.93
-463.54
Net margin %
-123.7
-260.97
-78.82
-15.42
-44.66
-49.91
-485.3
Liquidity ratios
Quick ratio
—
3.69
4.54
4.46
3.92
4.92
18.07
Current ratio
6.17
3.75
4.57
4.48
3.92
5.1
18.86
Inventory turnover
—
0.6
1.15
0.46
1.39
0
0
Asset turnover
0.3
0.22
0.49
0.2
0.54
0.58
0.59
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-2.4
-1.42
-1.26
-1.09
-1.28
-1.28
EBIT per share
—
-3.38
-1.98
-2.72
-1.77
-1.15
-1.16
EBITDA per share
—
-3.2
-1.78
-2.56
-1.65
-1.04
-1.04
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
2.06
1.77
1.63
2.92
0.91
6.55
Net current asset value per share
—
4.66
3.62
4.06
3.47
3.48
13.29
Tangible book value per share
—
4
2.31
2.46
1.85
0.88
3.93
Working capital per share
—
3.42
2.83
3.15
2.59
2.8
10.4
Book value per share
—
4
2.31
2.46
1.85
0.88
3.93
News
MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX)
MacroGenics at The Citizens Life Sciences Conference: Strategic Reemergence in 2026
MacroGenics at Leerink Global Healthcare Conference: Strategic Pipeline Focus
Stifel reiterates MacroGenics stock rating with $4 price target
MacroGenics Inc earnings missed by $0.03, revenue topped estimates
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates
Stifel reiterates Incyte stock rating after FDA setback
MacroGenics at TD Cowen Conference: Strategic Imperatives in Focus
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes